1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Jordan Pharmaceuticals and Healthcare Report Q4 2016

Jordan Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 90 pages

Includes 3 FREE quarterly updates



BMI View: Jordan presents an attractive pharmaceutical market for multinational pharmaceuticalcompanies - although its potential will remain impeded by the ongoing political and economic instabilitieswithin the region, which is having a detrimental impact on Jordan's healthcare sector. We expect Jordan'sdomestic pharmaceutical industry to continue to strengthen as consolidation and merger activity increasesin the country - both between domestic companies and in partnership with multinationals.

Headline Expenditure Projections

- Pharmaceuticals: JOD683mn (USD962mn) in 2015 to JOD727mn (USD1.02bn) by 2016; +6.4% inlocal currency terms and US dollar terms. Forecast unchanged from Q316.

- Healthcare: JOD2.03bn (USD2.85bn) in 2015 to JOD2.17bn (USD3.05bn) by 2016; +6.9% in localcurrency terms and US dollar terms. Forecast in line with Q316.

Table Of Contents

Jordan Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Jordan 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Jordan 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Jordan 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Jordan 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Jordan 2012-2020) 22
OTC Drug Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Jordan 2012-2020) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Jordan 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Jordan 2014-2020) 27
Industry Risk/Reward Index 28
Middle East and Africa Risk/Reward Index - Q4 2016 28
Jordan Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 39
Intellectual Property Issues 40
Pricing And Reimbursement Regime 42
Market Overview 45
Healthcare Sector 46
Table: Healthcare Resources (Jordan 2010-2015) 50
Table: Healthcare Personnel (Jordan 2010-2015) 50
Table: Healthcare Activity (Jordan 2010-2015) 51
Research and Development 51
Clinical Trials 52
Epidemiology 54
Competitive Landscape 57
Research-Based Industry 57
Table: Multinational Market Activity 60
Generic Drugmakers 61
Pharmaceutical Distribution 61
Pharmaceutical Retail Sector 62
Company Profile 63
Dar al-Dawa 63
Hikma Pharmaceuticals 66
Jordanian Pharmaceutical Manufacturing Company (JPM) 71
Pharma International Company 74
United Pharmaceutical Manufacturers 76
Demographic Forecast 79
Jordan Demographic Forecast 79
Table: Population Headline Indicators (Jordan 1990-2025) 80
Table: Key Population Ratios (Jordan 1990-2025) 80
Table: Urban/Rural Population and Life Expectancy (Jordan 1990-2025) 81
Table: Population By Age Group (Jordan 1990-2025) 81
Table: Population By Age Group % (Jordan 1990-2025) 82
Glossary 84
Methodology 86
Pharmaceutical Expenditure Forecast Model 86
Healthcare Expenditure Forecast Model 86
Notes On Methodology 87
Risk/Reward Index Methodology 88
Index Overview 89
Table: Pharmaceutical Risk/Reward Index Indicators 89
Indicator Weightings 90

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.